Has Olusegun Olusesi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $47,336 in general payments to Olusegun Olusesi, MD across 253 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Olusegun Olusesi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Olusegun Olusesi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Olusegun Olusesi, MD

Clinical Cardiac Electrophysiology · Norfolk, VANPI 1598923583

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (43.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Abbott at 55.2% of the total. 2025 is the largest year on record at $17,430, 2.2 times the $7,930 reported in 2019.

$47,336in general payments, 2019–2025

Across 253 payments — averaging $187.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$26K
Boston Scientific$11K
Medtronic$6K
Biotronik Inc.$2K
Biosense Webster, Inc.$2K
Medical Device Business Services, Inc.$787
plus $263 from 2 others

$92,427in research payments, 2019–2025

Across 17 payments — averaging $5436.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$92K

What the payments were for

Consulting fees$10,77623%
Speaking & faculty fees$5,31311%
Travel & lodging$20,59944%
Food & beverage$10,47522%
Education$700%
Other$1040%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	118	$26,132
Boston Scientific	29	$10,574
Medtronic(2 entities)	67	$6,318
Biotronik Inc.	16	$1,644
Biosense Webster, Inc.	15	$1,619
Medical Device Business Services, Inc.	4	$787
Inari Medical, Inc.	3	$159
Welch Allyn	1	$104

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Farapulse$7,697
ENSITE PRECISION$6,958
TACTICATH ABLATION CATHETER, SENSOR ENABLED$5,844
Ensite Cardiac Mapping System$5,743
AVEIR$4,008
Carto 3$2,095
RHYTHMIA$1,553
ENSITE$955
S-ICD System Magnet$838
Micra$490
Orsiro$399
EnSite Precision Cardiac Mapping System$158
LINQ II$125
COBALT DR MRI SURESCAN$107
Percepta$101

How this compares

$47,336 in reported general payments places this provider in the 75th percentile of 90 clinical cardiac electrophysiology providers in Virginia.

See all clinical cardiac electrophysiology providers in Virginia →

Medicare billing

Part B allowed, 2024

$442,214

Medicare patients

2,266

Services billed

6,156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	343	$317,074
XareltoRivaroxaban	65	$80,751
MultaqDronedarone Hcl	47	$56,284
Dofetilide	96	$24,491
Mexiletine Hcl	37	$5,308
Flecainide Acetate	95	$3,375
Diltiazem 24hr Er (Cd)Diltiazem Hcl	49	$2,016
Amiodarone Hcl	78	$1,058
SotalolSotalol Hcl	41	$992
Metoprolol Succinate	33	$830
Warfarin Sodium	42	$362
Metoprolol Tartrate	37	$166
Carvedilol	19	$94

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Norfolk

Jeffrey HedleyNorfolk$20K
Kenneth EllenbogenRichmond$360K
Brett AtwaterFairfax$319K
Oliver MonfrediCharlottesville$231K
Peem LorvidhayaFredericksburg$230K
Erich KiehlNewport News$181K
Emmanuel EkanemWinchester$132K
Pamela MasonCharlottesville$130K
Ajay PillaiRichmond$129K
Stephen GaetaFairfax$85K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →